ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
2696Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in Veeva by 96 shares, the number of shares held decreased 0.23% compared to the previous period and now represents 0.73% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 62 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 0.96% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 106 shares, the number of shares held decreased 0.23% compared to the previous period and now represents 1.19% of the total position.
ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 9,273 shares, the number of shares held increased 0.46% compared to the previous period and now represents 2.97% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 1,182 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 3.2% of the total position.
ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 7,884 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 1.11% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 324 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 1.09% of the total position.
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 11,912 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 1.63% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 26,156 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 1.88% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 442 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 2.26% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 5,310 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 2.83% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 11,388 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 2.35% of the total position.
ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 3,804 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 2.45% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 2,622 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 3.87% of the total position.
ARKG Investment Tracker position change: Decreased position in CareDx by 5,080 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 3.43% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 7,838 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 4.19% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 27,814 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 3.96% of the total position.
ARKG Investment Tracker position change: Decreased position in Illumina by 992 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 4.55% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 592 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 4.59% of the total position.
ARKG Investment Tracker position change: Decreased position in Tempus AI by 4,012 shares, the number of shares held decreased 0.24% compared to the previous period and now represents 9.35% of the total position.
Go to Tiger App to see more news